Related by context. All words. (Click for frequent words.) 86 mGluR2 mGluR4 mGluR5 mGluR7 69 regarding allosteric modulators 68 mGluR4 mGluR2 mGluR5 60 substrates inhibitors 59 futureperformance 59 coronary vasodilation 59 beta adrenergic receptor agonists 59 uncertainties materializes FICO 58 TRIOLEX HE# APOPTONE HE# 58 TriPath Oncology 58 futureresults 58 TRANSDUR ® 57 Receptors GPCRs 57 factors ZFP TFs 57 5 HT6 57 causeactual results 57 Azixa ™ 57 XL# anticancer compounds 57 QUADRAMET R 57 CYP#A# CYP#D# 56 Factor VIIa Factor VIII 56 peptidic compound 56 CORLUX CORT # 56 5 HT2A serotonin 56 created ZFP transcription 56 differ materiallyfrom 56 SUPPRELIN LA DELATESTRYL 56 crinobulin 56 EVENT TRANSCRIPT 56 IS BEING MADE ONLY 56 differmaterially 56 BUSINESS DAYS 56 monoclonal antibody IgG1 Mab 56 ARE MADE AS 56 5 HT1A receptor 56 forward lookingstatements 55 Epigenetics refers 55 Resonator ™ device 55 GlycoPEGylated hemostasis compounds 55 GearUpForSports makes 55 THE TERMS AND CONDITIONS 55 biomimetics non 55 absolutely NO RETURNS 55 VERIFICATION OF THE 55 successfully commercialize Silenor 55 EHSK 55 couldcause actual results 55 novel VDA molecule 55 ARE BASED UPON 55 palonosetron hydrochloride Injection Dacogen 55 FREE MAIN LISTING SIGN 55 CONTAINED IN THIS 55 CEP NEWS AND OTHER 55 Tasigna prolongs 55 receptor partial agonist 55 Antigen Express website 55 HMG CoA reductase inhibitors 55 successfully commercialize Iluvien 55 SANCTURA SANCTURA XR VANTAS 55 SIDE EFFECTS CHEAP ONLINE 55 WITHDRAW ANY ITEM 55 Rexahn actual 55 DAYS AFTER SALE DATE 55 superpotent ingredients Saben 55 S ROSE HILL 55 OR REFLECT THE 55 basilar migraine 55 INFORMATION ABOUT THE PROPOSED 55 html entity decode 55 AND ALL SALES 55 markets HP Acthar 55 Cytogen marketed 55 AND ARE SUBJECT 55 WEB SITE OR 55 STATEMENTS OF CURRENT 55 THE REPORTING 55 ADSI cautions 55 mitotic kinesins 55 LOOKING STATEMENTS TO REFLECT 54 pentadentate logo R 54 Disclaimer Past performance 54 SearchHelp communications 54 certain protein tyrosine 54 cause cardiac channelopathies 54 ARE ONLY PREDICTIONS 54 AccessIT undertakes 54 THE STATEMENTS WHICH 54 DISTRIBUTION OR 54 BioSante licensees 54 ARE BEING MADE SOLELY 54 R sorafenib tablets 54 CONTAINS FORWARD LOOKING STATEMENTS 54 ALN HPN 54 OmniComm intends 54 website www.competitivetech.net 54 hyaluronic acid DYNACIN R 54 Long acting beta2 54 NO RETURNS BASED ON 54 AFFECT MICROSEMI 'S 54 TSX VENTURE GAP 54 oxandrolone USP 54 ALL PACKING & 54 R Saizen R 54 oral transdermal 54 ANY WAY WITHOUT 54 YOUR OWN BLOG AD 54 ALN PCS 54 otherfactors 54 Charmer Charts shall 54 CDK cyclin dependent 54 corticotropin injection 54 PRODUCTS OR PRICING CHANGES 54 rheumatoid arthritis thrombocytopenia 54 SPEAK ONLY AS 54 CoTherix logo 54 UNCERTAINTIES OR OTHER 54 Rexahn licensees 54 xMAP Technology 54 OxyContin Chernoff 54 ENTIRETY BECAUSE THEY CONTAIN 54 developments affecting SIAF 54 Telik logo TELINTRA 54 accuracy adequacy 54 inflammatory autoimmune diseases 54 ITS REGULATION PROVIDER AS 54 ENZO 'S TAVERN 54 rheumatoid arthritis inflammatory bowel 54 REQUIREMENTS AND 54 orally bioavailable mimics 54 BY MICHAEL PUFFER 54 DIRECTLY OR INDIRECTLY 53 HuCAL PLATINUM ® CysDisplay 53 TO BE ACCURATE 53 Thalomid ® 53 ARE NOT INDICATIVE OF 53 By Thomas Gryta 53 FROM ANY FUTURE 53 THE WINDS WILL 53 AND SHOULD ALSO 53 THE TIME ALLOWED 53 CONTAINS CERTAIN FORWARD LOOKING 53 www.citi.com 53 Through Glycoscience R 53 AND OTHER RELEVANT POLICIES 53 Company Nasdaq RGDX 53 OR ACHIEVEMENTS TO BE 53 OTCBB FROI 53 OFFER TO PURCHASE LETTER 53 THE INFORMATION PROVIDED 53 OR REVISE ANY FORWARD 53 Auxilium anticipates 53 OCCURRENCE OF UNANTICIPATED EVENTS 53 CONDUCT CONFIDENTIALITY CONFLICTS OF 53 ALL PROPERTIES ARE SOLD 53 CysDisplay R 53 OR THE APPLICABLE 53 inhibitor PPI 53 OBLIGATION TO REVISE OR 53 Nasdaq RXII 53 STATEMENTS WITHIN THE MEANING 53 performance orachievements 53 THESE TERMS 53 FUTURE RESULTS 53 OF THE ORIGINAL 53 IS DEFINED IN 53 THE EXPRESSED WRITTEN CONSENT 53 contacting Kika Stayerman kika.stayerman 53 FACTORS NOT 53 nonhematologic adverse reactions 53 cholesteryl ester transfer 53 OF SECTION #A 53 MEK Inhibitor 53 ONCE STORAGE FEES 53 INTENDS PLANS BELIEVES SEEKS 53 COMPANY 'S AUDIO PRESENTATION 53 AND ASSUMPTIONS AND 53 CAN BE EXPECTED NEAR 53 PROVISIONS OF THE PRIVATE 53 2hours #mins #.#secs M 53 OMISSIONS OR INACCURACIES IN 53 Ronica Shannon 53 HAS BEEN PREPARED BY 53 servicio los lectores pero 53 THE PROPOSED TRANSACTION 53 IMPORTANT FACTORS THAT COULD 53 pancreatic prostate 53 THE ACCURACY OR 53 SHALL NOT BE LIABLE 53 tests miRview ™ 53 ARE AVAILABLE AT 53 COMPANY ASSUME ANY RESPONSIBILITY 53 BECAUSE THEY WILL CONTAIN 53 DEBT AND IDENTITY 53 MAY CONTAIN FORWARD LOOKING 53 Solazed TM 53 www.twitter.com otcadvisors 53 Nonsteroidal anti inflammatory 53 THE COMPANY UNDERTAKES NO 53 SHALL NOT CONSTITUTE AN 53 ABLYNX 53 ARE FINAL 53 het archief 53 ACC2 53 DOES SEEKING ALPHA ASSUME 53 OF THE ABOVE 53 STATEMENTS IN 53 NEWS RELEASE THE COMPANY 53 differ materially fromthose 53 ENTER OR USE 53 #CL# 53 serious cardiovascular thrombotic 53 SIX BSLN 53 ACTUAL PURCHASE PRICE 53 affecting BEO Bancorp 53 inhibit KSP 53 MADE BASED UPON 53 Jaime Cone 53 paroxetine sertraline 53 Apolipoprotein E4 53 tranquilizers diazepam 53 unproven detoxification 53 THE ADEQUACY OR 53 AirTran Airways reservations 53 REGARDING THE PROPOSED MERGER 53 forward lookingstatement 53 QUALITY AND 53 rheumatoid arthritis multiple sclerosis 53 include BioNeutralizers 53 AGAIN ALL SALES 53 IS NOT INDICATIVE OF 53 ALL WARRANTIES EXPRESS 53 CONTROL WHICH MAY CAUSE 53 R DYNACIN R 53 www.isignmedia.com 53 proprietary Capillary Aerosolization Technology 53 OF THIS SITE 53 JAK2 enzyme 53 OR ACHIEVEMENTS IMPLIED 53 ANY RESPONSIBILITY FOR ANY 53 events thrombocytopenia neutropenia 53 IS FOR INFORMATIONAL 53 RAF kinase VEGFR 53 ANY VOTING OR 53 affecting ChinaNet 53 Technicalanalysisreports.com 53 Severe hypersensitivity reactions 53 MANAGEMENT 'S CURRENT BELIEFS 53 anyforward looking 52 RISKS AND UNCERTAINTIES INHERENT 52 prostanoid 52 'S PRESENT BELIEFS AND 52 tumor lysis syndrome 52 DOUBTS WE PREFER THAT 52 THE AUCTIONEER RESERVES 52 REJECT ANY BID 52 NO HYPOTHETICAL TRADING 52 thromboxane A2 52 Moneylife Magazine 52 kkadlec@cnc.com 52 infringed misappropriated invalid 52 INCLUDE CHANGES IN 52 www.citigroup.com 52 involve risksand uncertainties 52 DIFICID ™ 52 STATED IN THE 52 email lovecoach@hotmail.com 52 UNCERTAINTIES OR OTHER FACTORS 52 stardelhi@stny.rr.com 52 WAIVER OF WARRANTY 52 SIRT1 activators 52 Cyclooxygenase 2 52 www.palatin.com 52 PINNACLEDIGEST.COM S PAST PERFORMANCE 52 Thrombin topical Recombinant 52 STATEMENTS RELATING TO 52 ordinarily harmless bacteria 52 THE ACCURACY OF 52 RELATIVELY GOOD PERFORMANCE DETECTED 52 ARE BASED UPON HRP 52 CAN NOT AND 52 DIRECTORS OF GREAT QUEST 52 INVESTORS ARE URGED TO 52 http:/www.optimerpharma.com 52 BY PAUL HUGHES 52 BioNeutral antimicrobial formulations 52 degrades another 52 AN INDICATION OF 52 INTEREST AFFILIATE FIREWALL COMPLIANCE 52 theseforward looking 52 BY JIM MOORE 52 HAS ATTEMPTED TO IDENTIFY 52 GALLERY CAN EXERCISE 52 http:/www.tripos.com 52 OR ACCURACY OF 52 Doral ® quazepam 52 AND FUTURE EVENTS 52 OR HISTORICAL FACT 52 NEAL AUCTION COMPANY DOES 52 RECOMMENDATIONS TO PURCHASE SELL 52 spytak@republicanherald.com 52 SITE MOMENTO#.COM DO NOT 52 risks anduncertainties 52 Moneylife.in website 52 prescription brands RESTYLANE 52 BELIEVES THAT THE 52 collaborators Shalev 52 matt.erickson @ brainerddispatch.com 52 These statementsare 52 PAIVIS actual 52 HYPOTHETICAL OR SIMULATED PERFORMANCE 52 Zemiva TM Trofex TM 52 CERTAIN IMPORTANT INFORMATION 52 super oxide dismutase 52 TELINTRA 52 developing ostarine selective 52 #-# @ missoulian.com 52 StarNet www.azstarnet.com may 52 AN ACCURATE TRANSCRIPTION THERE 52 LATEST WRESTLING NEWS 52 TO ITS ACCURACY 52 ARE REASONABLE THERE CAN 52 OR INFORMATION 52 By Gabriel Rizk 52 AND TO REOFFER 52 AFFILIATES AGENTS AND LICENSORS 52 AND CONDITIONS TO 52 expressed orimplied 52 Xlibris books 52 CONTAIN FORWARD LOOKING STATEMENTS 52 SOLICITATION WILL PROVIDE COPIES 52 ENTIRETY WHEN THEY BECOME 52 amlodipine beta blockers 52 THE COMPANY TO BE 52 REPORTS FILED WITH 52 Azedra TM Onalta TM 52 SpectraScience actual 52 OF THE COMPANY 52 THAT COULD CAUSE ACTUAL 52 Pervasip actual 52 BY DAVID KRECHEVSKY 52 DATA ARE FORWARD 52 Reporter Kurt Bresswein 52 Shire Attention Deficit 52 BY ANDREW LARSON 52 lgierer@ledger-enquirer.com 52 systemic immunosuppressive drugs 52 suchforward looking 52 ESTIMATES VARIATIONS OF SUCH 52 OF THE SUBSTANCE 52 EXPECTATIONS BUT THESE STATEMENTS 52 pancreatic alpha 52 fwiggins@progress-index.com 52 OR QUOTES ALL 52 BY COPYRIGHT LAW 52 intentions anticipations beliefs 52 offering secu rities 52 THE FOOD RETAIL 52 REDUCED DEMAND FOR 52 OR NATURE 52 IL #p# 52 pRb 52 RISK FACTORS DISCLOSED IN 52 domain apa az.info 52 risksand uncertainties 52 OR INFORMATION RELATE 52 ChemoNeutralizers 52 DOW JONES AND ITS 52 IT WILL CONTAIN 52 Hiru Corporation 52 GOD DISCUSSION RESERVES 52 looking statementsare 52 www.immunogen.com 52 AREAS AFFECTED 52 AWAY FROM WINDOWS 52 LOOKING STATEMENTS WHICH ARE 52 www.telik.com 52 STATEMENT BECAUSE IT CONTAINS 52 slshelton@freepress.com 52 dfujimoto@kauaipubco.com 52 VERTEX PHARMACEUTICALS 52 Pokerräume im Internet vor 52 limitedto 52 AMONG THE FACTORS THAT 52 Blueberry Goji Fruit Punch 52 By PK ABDUL 52 DRIVERS HAVE 52 MATERIALLY FROM ANY FUTURE 52 protein tyrosine phosphatases 52 AND CONSENT SOLICITATION 52 Commentary submitted 52 acquires researches develops 52 BY MICHELLE SHAW 52 irresponsible nuisances 52 ABOUT THE PROPOSED 52 TO IDENTIFY SUCH FORWARD 52 Darinaparsin Zinapar TM 52 Nasdaq RXII recognized 52 rapamycin derivatives 52 WAS PREPARED BY KINBAURI 52 â € œwill â 52 THEY BECOME AVAILABLE BECAUSE 52 ovarian breast 52 therapeutically beneficial 52 THIS CATALOGUE IS WARRANTED 52 anthracycline induced 52 THEREON 52 ANTICIPATES TARGETS GOALS PROJECTS 52 OR OTHER PROFESSIONAL FINANCIAL 52 EXPRESSED OR IMPLIED 52 INFORMATION INCLUDING THE TERMS 52 E mail asklogility@logility.com 52 NO ASSURANCE THAT 52 Casino Bonus und 52 INFORMATION SET FORTH HEREIN 52 ACCOUNT OR 52 suchstatements 52 results performance orachievements 52 INTRODUCTION OF NEW 52 todiffer materially 52 AND FITNESS FOR 52 die besten Deutsche 52 OR INVESTMENT DECISION 52 Dieses Portal stellt Ihnen 52 PREMIERSHIP CHELSEA v 52 BY MATTHEW O'ROURKE 52 bloody diarrhea kidney 51 Xlibris bookstore 51 mergers dispositions 51 IS INTENDED FOR DISTRIBUTION 51 Reporter Edward Sieger 51 AND INCREASING 51 futureevents 51 Announce Monthly Distributions 51 THE CONTENT 51 OF HINDSIGHT 51 lipid particles SNALP 51 uncertaintiesthat 51 RESULTS PERFORMANCE OR ACHIEVEMENTS 51 mycophenolic acid 51 AS IT CONTAINS 51 PURPOSE OF SAFE HARBOR 51 info@inin.com 51 Computerworlds internasjonale nyheter leveres 51 ADDRESS ANY OTHER 51 BASIS AND 51 manufacture PolyHeme 51 ADSI reliance 51 MOVE IN TANDEM 51 EXPRESS OR IMPLIED WARRANTIES 51 AS THEY WILL CONTAIN 51 STATEMENT IS 51 SENOMYX ANNOUNCES 51 STATEMENTS CONTAINING FORWARD LOOKING 51 PUBLIC WEBSITE WWW.FITCHRATINGS.COM 51 ARE NOT HISTORICAL FACTS 51 adenosine A2A 51 brain neurotransmitter 51 THAT THEY ARE DESIGNED 51 AVAILABLE AND 51 THE APPLICABLE COMPANY ASSUME 51 COPIED OR REPRODUCED IN 51 Seliciclib CYC# 51 Zemiva TM 51 RELIANCE ON THESE FORWARD 51 DO NOT WARRANT THE 51 MAY DIFFER 51 THE COMPANY 'S 51 THE RESULTS PERFORMANCE 51 diesem Download empfangen 51 MUST BE PAID FOR 51 inherited mutations 51 STATEMENT CAREFULLY WHEN 51 RESPONSIBILITY FOR THE ADEQUACY 51 THAT SPEAK AS 51 THEY WILL CONTAIN IMPORTANT 51 AND ACTUAL RESULTS 51 UPON RECEIPT BY 51 COMPANY 'S SEC FILINGS 51 http:/www.marinabio.com 51 monocytogenes Listeria vaccines 51 APPROVES NOR DISAPPROVES OF 51 YOUR OWN BLOG 51 INTENTIONS CONTAINED IN 51 CUSTOMERS WILL BE REQUIRED 51 BY REPRESENTATIVES OF 51 TM Aganocide 51 RESULTS TO DIFFER 51 COVER YOUR BODY 51 CODE OF CONDUCT SECTION 51 BY MARC SILVESTRINI 51 DATE HEREOF AND 51 FOR REDEMPTION BY 51 WHILE THE COMPANY 51 OF ORIGINALITY ACCURACY TIMELINESS 51 www.vivakor.com 51 PLAN OR EXPECT 51 MAY OBTAIN 51 RISKS DELAYS AND UNCERTAINTIES 51 find torrents keygens 51 Michelle Durand 51 PRESS RELEASE ARE FORWARD 51 AMPS Risk 51 LOOKING STATEMENTS WHICH INVOLVE 51 AGREE WITH ANY OF 51 SMARTREND WATCHING FOR 51 REGULATORS IN THEIR ENTIRETY 51 www.hanabiosciences.com 51 STATEMENT WHEN IT BECOMES 51 THAT PEOPLE 51 AS ESTIMATE ANTICIPATE BELIEVE 51 http:/www.mappharma.com 51 CAUTIONARY STATEMENT UNDER 51 venob@knews.com 51 AND CONDITIONS OF 51 BELIEFS PLANS EXPECTATIONS AND 51 THAT TERM IS DEFINED 51 WARRANTIES PARTS OR ALL 51 BUT WHEN YOU 51 BY ANDY PIPER 51 TSX CTI 51 www.royalcaribbean.com www.celebrity.com www.pullmAhmed Hilles clan 51 SIGNED BY AUCTIONEER AND 51 THE BIDDER HAS 51 pachen@mailtribune.com 51 AND INFORMATION INCLUDE 51 Vytorin combines 51 contain racism homophobia 51 BY ROB DOWDY 51 HEREBY DISCLAIMS ANY SUCH 51 AND RECOMMENDED ACTIONS 51 ITS ENTIRETY BECAUSE 51 ALTHOUGH THE COMPANY 51 Newtek beliefs 51 FITCH 'S CODE OF 51 SEA SEA 51 SUCH FORWARD LOOKING STATEMENTS 51 By JOE STEVENSON 51 IS NOT FOR DISSEMINATION 51 MAY INCLUDE FORWARD LOOKING 51 Limited Shenzhen AIVtech 51 aux abonnés 51 either acutely decompensated 51 ARE PROVIDED ON 51 HAS NOT REVIEWED AND 51 constituteforward looking 51 Deregulation section details 51 ACCORDINGLY NO ASSURANCES CAN 51 LIMITATION MAY NOT APPLY 51 REBETOL combination 51 diphosphate 51 asume ninguna responsabilidad sobre 51 DOES NOT INVOLVE FINANCIAL 51 INVOLVE RISKS AND UNCERTAINTIES 51 SUCH FACTORS INCLUDE AMONG 51 news.de ein Presseportal der 51 PURCHASE INSURANCE 51 RapMAT ® 51 Fampridine SR Acorda Therapeutics 51 THAT ARE SUBJECT TO 51 rainwater dripped onto 51 immunotherapies 2A/Furin 51 THe ORIGINAL CREDITOR WITHIN 51 Intellon ICs 51 EVANGELIST Staff writer 51 IN HOUSE SHIPPING 51 INFORMATION TECHNOLOGY EQUIPMENT 51 RESPONSIBLE FOR ANY DELAY 51 DOES THOMSON FINANCIAL 51 IS PROVIDED AS IS 51 vii Cubist ability 51 WITH FUTURES PRICES 51 Aflibercept VEGF Trap 51 OBLIGATED TO REVISE OR 51 ANY OF ITS AFFILIATES 51 mcclearyn@fayobserver.com 51 damage cirrhosis liver 51 ATK undertakes 51 REGISTRATION STATEMENT BECAUSE THEY 51 affecting orBec ® 51 actualresults 51 READ THE PROXY 51 CONTAIN IMPORTANT INFORMATION INCLUDING 51 adjuvant GIST 51 MATERIALLY DIFFERENT FROM 51 READ AND UNDERSTANDS 51 involving hydrophilic liquid 51 Flamel Technologies Announces 51 THE MATERIALS AND 51 OWN BLOG AD 51 FACTORS THAT CAN MATERIALLY 51 looking statements.These 51 bio lipids 51 including thyroiditis RA 51 THE OPTION MAY 51 robber baron cruelty 51 OF VARIOUS PROJECT 51 DEPUTY SUPREME COMMANDER SHAIKH 51 THE MERGER CAREFULLY AND 51 OTCBB ZVTK 51 INSURANCE IS 51 MATT ERICKSON 51 Dyax logo 51 OPENINGS GROSS MARGINS EXPENSES 51 BY JOHN MCKENNA 51 cytokines chemokines 51 YOUR INVOICE 51 REPRESENTS THE EXPECTATIONS 51 ZANAFLEX CAPSULES ® tizanidine 51 By TERESA ANN 51 UNITED STATES PRIVATE SECURITIES 51 WITH HIGHER GUSTS 51 TO MATERIALLY DIFFER 51 diclofenac Voltaren 51 VARIOUS TERMS OF 51 AN AS IS 51 Doral R quazepam 51 WITH THE BENEFIT 51 induce diuresis 51 LTD ACN # MMAL 51 RESULTS TO BE 51 WILL BE AFFECTED BY 51 THE TIME PROVIDED 51 INVESTORS SHOULD NOT 51 CONTENT PROVIDERS OR LICENSORS 51 INFORMATION CONTAINED IN 51 Funds Declare Dividends 51 MEANS CONSTITUTES YOUR ACKNOWLEDGMENT 51 die besten online 51 Airvana anticipates 51 CONTROL IN PROCURING COMPILING 51 Kopiowanie redagowanie i wykorzystywanie 51 REQUIRED BY APPLICABLE CANADIAN 51 revise anyforward looking 51 WAS AGAINST 51 THAT ALLOWS 51 PolyHeme successfully 51 Zemiva ™ 51 Wirtschaftsmeldungen auf ad hoc 51 statins fibrates 51 INFORMATION PROVIDERS EXPRESSLY DISCLAIMS 51 JODIE TWEED 51 DISPLAY AND SEARCH THE 51 Solzira TM 51 aEURoeforward looking 51 'S WEBSITE AT WWW.SEC.GOV 51 MOST RECENTLY FILED ANNUAL 51 Vascular Endothelial Growth 51 EXPECTATIONS AND ARE SUBJECT 51 affect Pennichuck Corporation 51 PURSUANT TO THE 51 AVAILABLE BECAUSE THEY CONTAIN 51 AND THE TERMS 51 created = num 51 SECURITIES COMMISSION OR OTHER 51 DEVELOPMENT EFFORTS WILL SUCCEED 51 asvaldi@denverpost.com 51 developing ACAPODENE 51 indications Cytokinetics 51 RR Donnelley disclaims 51 THE FUTURES CHARTS 51 PAYMENT IS DUE WITHING 51 SHALL THE LIABILITY OF 51 HELINE 51 THAT YOU GUYS 51 RENEE RICHARDSON 51 SUCH INFORMATION 51 AND NON INFRINGEMENT 51 BEFORE ANYONE ELSE 51 THE COMPANY 'S PERIODIC 51 www.ardenb.com 51 FOR INFORMATIONAL PURPOSES ONLY 51 PROSPECTUS PROXY STATEMENT BECAUSE 51 BY KYLE BURCH 51 OF CERTAIN TYPES OF 51 BY THESE FORWARD 50 WITHOUT ANY WARRANTIES 50 ANY INVESTMENT DECISION UPON 50 THE RELEASE WHICH 50 chocolate oatmeal raisin 50 TECHNOLOGICAL AND OPERATIONAL NATURE 50 update anyforward looking 50 BY PAUL SINGLEY 50 Neurogen disclaims 50 TO PLACE UNDUE 50 fsawyer@freedomenc.com 50 OTHER THAN PURELY HISTORICAL 50 BY MICHAEL SCHMIDT 50 BASED ON NUMEROUS ASSUMPTIONS 50 ENTRY INTO SWEEPSTAKES 50 www.facebook.com/pages/OTC-ADVISORS-LLC/#veejay 50 Lexicon undertakes 50 woolvertonp@fayobserver.com 50 PERFORMANCE OR ACHIEVEMENTS 50 receiving INTRON 50 MATERIALLY FROM CURRENT EXPECTATIONS 50 J. COTSONIKA 50 rshannon@richmondregister.com 50 OUR FEATURED COMPANIES ARE 50 regarding Heska 50 PLEASE BE COMFORTABLE WITH 50 ITSELF AND THE APPLICABLE 50 website www.corcept.com 50 INCLUDES FORWARD LOOKING STATEMENTS 50 AT WWW.SEC.GOV 50 ARE BASED ON 50 INFORMATION INCLUDING STATEMENTS RELATING 50 Kuvan R 50 DECISION WITH RESPECT TO 50 INACCURACIES IN THE DOW 50 @ Mobilewhack 50 orBec ® oral beclomethasone 50 kbresswein@express-times.com 50 OTHER FACTORS THAT CAUSE 50 reflect events orcircumstances 50 CAN BE IDENTIFIED BY 50 JOINT PROXY STATEMENT PROSPECTUS 50 COMPANY WE STRONGLY 50 operates CTS Teleradiology 50 OFFER BECAUSE THEY CONTAIN 50 BEFORE MAKING ANY VOTING 50 OFFERED FOR SALE 50 MAKES ANY 50 FUTURE EVENTS OR CIRCUMSTANCES 50 THE COMPETITIVE MARKETPLACE 50 Please LOGIN 50 Isis# where 50 contains vulgar profane 50 OR THE EXCLUSION 50 Antithrombin 50 ARE BIDDING ON 50 akravetz@pjstar.com 50 pharmacokinetic equivalence 50 LIMITATIONS OF INTERNET TRANSMISSION 50 DILIGENCE BEFORE INVESTING IN 50 BY AMY DeMELIA 50 DexaSite 50 ARTICLES SOLELY FOR YOUR 50 DO THEIR OWN DUE 50 AT HTTP :/ 50 involve risks anduncertainties 50 VIA THE WORLD 50 WARRANTIES ARE HEREBY EXPRESSLY 50 NNL preferred 50 THE AMENDED SCHEDULE 50 OBLIGATION TO UPDATE 50 PhotoChannel operates 50 UNBEATEN RECORD 50 AVAILABLE FROM THE 50 CEO WE SEEK 50 FIRST DEGREE MURDER 50 PAST RESULTS 50 e mail michelle@smdailyjournal.com 50 beyond Explor 50 OF DESCRIPTION GENUINENESS 50 DAVIESS 50 THE ITEMS YOU 50 STATEMENTS OF HISTORICAL FACT 50 TO READ THE PROXY 50 MATERIALS CAREFULLY BECAUSE THEY 50 shipper ie 50 PAST PERFORMANCE IS NOT 50 BY JIM DeROGATIS 50 N methyl 50 #-#-# dsicotte@echoesfinancial.com 50 Template Error loadfile While 50 SIMILAR EXPRESSIONS ARE INTENDED 50 EXCLUSIVE AUDIO CONTENT MEMBER 50 THIS SITE AT 50 KNOWN AND UNKNOWN RISKS 50 http:/www.thqwireless.com 50 Dona Harms managing 50 CONTAIN IMPORTANT INFORMATION ABOUT 50 modified phosphorodiamidate oligomers 50 d' IRIN sur http:/www.irinnews.org 50 PharMerica LTC Transaction 50 Software Seapine Software 50 INFORMATION CONTAINED HEREIN 50 THE SITE WITHOUT 50 AUTHORITIES SUCH AS 50 WE UNDERTAKE NO OBLIGATION 50 PenguinsLIVE sections 50 INTERPRETING REPORTING OR DELIVERING 50 ACTUAL RESULTS COULD DIFFER 50 http:/www.nansulate.com 50 areforward looking 50 TO ASSURE RECEIPT OF 50 RANGE VOL KANSAS CONFIRMED 50 OR INTENTIONS WILL PROVE 50 UNKNOWN RISKS UNCERTAINTIES AND 50 BY SUCH FORWARD 50 INVESTING IN SECURITIES INVOLVES 50 OFFER TO SELL OR 50 AND ORAL STATEMENTS MADE 50 battens@fayobserver.com 50 THEY SAY THE 50 SOURCEFIRE 3D ® 50 THE SECOND TOWER 50 NO BANK GUARANTEE 50 का है 50 ANY SUCH DOCUMENTS FILED 50 forward lookinginformation 50 CREDITOR WITHIN THE 50 THE SERVICE OR 50 unstable detrusor muscle 50 TSX VENTURE EXCHANGE NOR 50 expressively disclaims 50 Carl Rotenberg 50 Georox Resources Inc. 50 REGULATORY AUTHORITY HAS APPROVED 50 trading house.net AG 50 CEFF financings subject 50 targeted anticancer biopharmaceuticals 50 ATPace TM 50 SAFE HARBOR PROVISIONS OF 50 rbrundrett@thestate.com 50 VeraTag assays 50 WHICH ACCEPTS THE 50 fowlerb@knews.com 50 Sonneteer skim ortolan coccyalgia 50 OR ANY OTHER 50 CCR5 inhibitors entry 50 CHECKS WILL NOT BE 50 guarantees offuture performance 50 e mail EveningStarLetters@eveningstar.co.uk 50 STATEMENTS OR 50 Agria beliefs 50 P#X# antagonist 50 THE CALL WARRANTS 50 #ET Copyright c 50 BASED LARGELY ON 50 'S FUTURE PLANS 50 THE MORTGAGOR THE MORTGAGOR 50 transthyretin mediated amyloidosis ATTR 50 NOR DISAPPROVES OF 50 Abdullah Batarfi Yasir 50 BE READ 50 OTHERWISE EXCEPT AS REQUIRED 50 OF THIS REGULATION 50 DATE HEREOF 50 OF SOURCES FROM WHICH 50 PURPOSES ONLY AND 50 WILL PROVE TO BE 50 womens cialis pfizer cialis 50 acquisitions mergers dispositions 50 Package Stadium Arcadium 50 maycause actual results 50 OTHERWISE INCLUDING BUT NOT 50 CERTAIN RISKS AND UNCERTAINTIES 50 e mail lifestyle@readingeagle.com 50 APPROVAL OF THE 50 OR SIMILAR STATEMENTS ARE 50 ARE SOLD ON 50 PROPOSED AMENDMENTS TO EMMIS 50 MATERIALLY FROM THOSE CONTAINED 50 ACCORDINGLY READERS SHOULD NOT 50 Limited ACN # CBFC 50 phenylketonuria PKU developed 50 MATERIALLY FROM THOSE PROJECTED 50 Shire plc Attention Deficit 50 Abusive comments 50 www.nymox.com email info@nymox.com 50 INFORMATION AS 50 Serostim R 50 fusion enhancers 50 THE COMPANY CONTAIN CERTAIN 50 OFFER STATEMENT ON SCHEDULE 50 Indibulin Zybulin TM 50 Monopril 50 glial derived neurotrophic 50 STATEMENT PROSPECTUS REGARDING THE 50 Glufosfamide 50 MEXICO PERU ARGENTINA BOLIVIA 50 GENERAL ARE ALSO SUBJECT 50 pirate steve video 50 yet handle MBCS 50 THAT WILL MAKE 50 NeutroTest 50 brevity length 50 androgen receptor modulator 50 TNF blocker therapy 50 polyneuropathy HIV DSP 50 cyclooxygenase 50 ITS CONTENTS 50 airtran.com #.#.# Judy 50 FORWARD LOOKING STATEMENTS ARE 50 THAT CAUSE RESULTS 50 http:/www.unitedfamilyhospitals.com 50 THOMAS ZAMBITO 50 IS OBTAINED AND 50 without uremia 50 Reporter Tim Hearden 50 EVENTS LEADING TO 50 ONCE YOU OBTAIN 50 BE NO ASSURANCE 50 JENNIFER STOCKINGER 50 IS PROTECTED BY 50 时 的 50 raymond.legendre @ houmatoday.com 50 AGENTS OR LICENSORS SHALL 50 EXCHANGE OR 50 MAY BE OTHER FACTORS 50 ARE USED THEY IDENTIFY 50 TO THE PROPOSED 50 whatsoever warranties 50 AND DESTRUCTIVE WINDS IN 50 jodie.tweed @ brainerddispatch.com 50 TO REQUIRE 50 # EQUINOX INVESTMENT HOLDINGS 50 PLACE UNDUE IMPORTANCE ON 50 HOW MUCH HAS 50 NOT FDIC INSURED 50 6 sulfatase 50 Trust ETFS Silver 50 gilpinf@fayobserver.com 50 Divigel R 50 THESE STATEMENTS FOR REVISIONS 50 OR WEB SITE 50 PART OF ANY OTHER 50 reduce serum phosphate 50 TO THE COMPANY 50 AND RELATED MATERIALS BECAUSE 50 PLEASE MAKE PAYMENT ARRANGEMENTS 50 STATEMENT AND ANY OTHER 50 THE ELECTRONIC VERSION 50 Bulletin Staff Writer 50 OR MAY BE 50 Twitter @ noozhawk 50 ANY MATERIALS OR 50 max@politicsnj.com 50 GSI Commerce expressly disclaims 50 将 的 50 tiny pteropod 50 COULD DIFFER MATERIALLY FROM 50 www.vioquestpharm.com 50 IN YOUR RECEIPT OF 50 CYP #A# 50 OF AIRGAS ARE URGED 50 opioid tolerance 50 Laurion cautions against 50 ANY FORWARD LOOKING STATEMENTS 50 THE EXCLUSION OR LIMITATION 50 ACTUAL RESULTS PERFORMANCE 50 IN THE SOLICITATION 50 WILL BE USED FOR 50 SECURITY AND STABILITY 50 alnum answers = alnum 50 BY SAM COOPER 50 subjectto 50 www.ind.homeoffice.gov.uk 50 lung ovary 50 abdominal cramps fever 50 www.norsat.com 50 INVESTORS ARE CAUTIONED NOT 50 AND EXECUTIVE OFFICERS 50 Contact JOHN LOWE 50 IN BAKERS FOOTWEAR 'S 50 WHICH INCLUDES 50 MESSAGE BOARD ACCESS START 50 mother Robertina Sanchez 50 SNOW WILL DEVELOP 50 OF LIABILITY FOR DAMAGES 50 rsabalow@redding.com 50 INTERNATIONAL ORDERS AS WELL 50 UPDATE PUBLICLY ANY FORWARD 50 partner lorcaserin APD# 50 AND OPTIONS INVOLVES 50 BEACON ROOFING SUPPLY 50 logo Callidus TrueAnalytics 50 ADVICE TO PROSPECTIVE 50 ALEX ROARTY 50 developing chemokine 50 #-#-PKI-NYSE 50 AND CAN BE 50 SQUARE ENIX logo 50 Immersion disclaims 50 SEC WHEN THEY 50 PALIS PGAL SHOW 50 Antiplatelet agents prevent 50 Note SHIPPING CHARGES 50 Sie lesen Finanznachrichten und 50 STANDARD SHIPPING POLICY 50 TO READ THESE 50 Disclaimer Views 50 ANY EXPRESS OR 50 SteelersLIVE PiratesLIVE 50 Oral Solution OSMOPREP 50 near Nonconnah Creek 50 REVIEW THE APPLICABLE 50 OR CONTINGENCIES BEYOND ITS 50 ACCURACY COMPLETENESS CURRENTNESS TIMELINESS 50 VOLUME WATCH FOR 50 BEO Bancorp. There 50 COULD CAUSE ACTUAL RESULTS 50 By JIM RADCLIFFE 50 converting enzyme 50 Atheros disclaims 50 Contact MARK SNYDER 50 Gorzno Poland 50 OR EVEN MOVE